Extensively drug-resistant Acinetobacter baumannii (XDR-AB) is a major threat to public health worldwide. A retrospective study for 27 XDR-AB isolates from four tertiary hospitals in Thailand was conducted. Beta-lactamase and virulence genes were characterized by PCR. The blaADC, blaOXA-51, and blaOXA-23 were detected in all isolates, whereas blaPER-1 and blaNDM-1 genes were present in 7.4% and 3.7% of isolates. All isolates had virulence genes, including genes in iron acquisition system, biofilm formation and secretion systems. The plasmids in XDR-AB belonged to GR2 (100%), GR6 (40.7%), and GR1 (7.4%). Multilocus sequence typing sequence types (STs) were further investigated. The data demonstrated that XDR-AB isolates had nine STs: ST195 (n = 4), ST208 (n = 4), ST368 (n = 1), ST451 (n = 5), ST457 (n = 2), ST1947 (n = 1), ST1166 (n = 7), including two novel STs namely ST1682 (n = 2) and ST1684 (n = 1). We observed that the majority ST1166 (25.9%) was associated with the prevalence of GR2 and GR6 plasmids and traU virulence gene. Genome-based single nucleotide polymorphism phylogenetic analysis of the isolates with two novel ST types indicated that the two isolates belonged to the international clone II (IC2) within the same cluster. In conclusion, our data showed the dissemination of XDR-AB isolates harbored virulence genes and antibiotic resistance genes among four hospitals in Thailand. The results highlighted the difficulty posed for the empirical treatment of the patients with the A. baumannii infection.
Get full access to this article
View all access options for this article.
References
1.
Garnacho-MonteroJ., and Amaya-VillarR.. 2010. Multiresistant Acinetobacter baumannii infections: epidemiology and management. Curr. Opin. Infect. Dis. 23:332–339.
2.
MarchandI., Damier-PiolleL., CourvalinP., and LambertT.. 2004. Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system. Antimicrob. Agents Chemother. 48:3298–3304.
3.
TomarasA.P., FlaglerM.J, DorseyC.W, GaddyJ.A, and ActisL.A.. 2008. Characterization of a two-component regulatory system from Acinetobacter baumannii that controls biofilm formation and cellular morphology. Microbiology. 154:3398–3409.
4.
ThummeepakR., KongthaiP., LeungtongkamU., and SitthisakS.. 2016. Distribution of virulence genes involved in biofilm formation in multi-drug resistant Acinetobacter baumannii clinical isolates. Int. Microbiol. 19:121–129.
5.
EijkelkampB.A., HassanK.A, PaulsenI.T, and BrownM.H.. 2011. Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC Genomics. 12:1–14.
6.
PenwellW.F., ArivettB.A, and ActisL.A.. 2012. The Acinetobacter baumannii entA gene located outside the acinetobactin cluster is critical for siderophore production, iron acquisition and virulence. PLoS One. 7:1–12.
BogaertsP., NaasT., El GarchF., CuzonG., DeplanoA., DelaireT., HuangT.D, LissoirB., NordmannP., and GlupczynskiY.. 2010. GES extended-spectrum β-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob. Agents. Chemother. 54:4872–4878.
9.
HojabriZ., PajandO., BonuraC., AleoA., GiammancoA., and MamminaC.. 2014. Molecular epidemiology of Acinetobacter baumannii in Iran: endemic and epidemic spread of multiresistant isolates. J. Antimicrob. Chemother. 69:2383–2387.
10.
GomaaF.A.M., HelalZ.H, and KhanM.I.. 2017. High prevalence of blaNDM-1, blaVIM, qacE and ΔqacE 1 genes and their association with decreased susceptibility to antibiotics and common hospital biocides in clinical isolates of Acinetobacter baumannii. Microorganisms. 5:1–15.
11.
LiuY., and LiuX.. 2015. Detection of AmpC β-lactamases in Acinetobacter baumannii in The Xuzhou region and analysis of drug resistance. Exp. Ther. Med. 10:933–936.
12.
Tuan AnhN., NgaT.V, TuanH.M, N.S. TuanD.M. Y, Vinh ChauN.V, BakerS., and DuongH.H.. 2017. Molecular epidemiology and antimicrobial resistance phenotypes of Acinetobacter baumannii isolated from patients in three hospitals in southern Vietnam. J. Med. Microbiol. 66:46–53.
13.
BertiniA., PoirelL., MugnierP.D, VillaL., NordmannP., and CarattoliA.. 2010. Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob. Agents Chemother. 54:4168–4177.
14.
PovilonisJ., SeputieneV., KrasauskasR., JuskaiteR., MiskinyteM., SuziedelisK., and SuziedelieneE.. 2013. Spread of carbapenem-resistant Acinetobacter baumannii carrying a plasmid with two genes encoding OXA-72 carbapenemase in Lithuanian hospitals. J. Antimicrob. Chemother. 68:1000–1006.
15.
SaranathanR., SudhakarP., KarthikaR.U, SinghS.K, ShashikalaP., KanungoR., and PrashanthK.. 2014. Multiple drug resistant carbapenemases producing Acinetobacter baumannii isolates harbours multiple R-plasmids. Indian J. Med. Res. 140:262–270.
16.
LiuC.C., KuoH.Y, TangC.Y, ChangK.C, and LiouM.L.. 2014. Prevalence and mapping of a plasmid encoding a type IV secretion system in Acinetobacter baumannii. Genomics. 104:215–223.
17.
DiancourtL., PassetV., NemecA., DijkshoornL., and BrisseS.. 2010. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One. 5:1–17.
18.
KimD.H., ChoiJ.Y, KimH.W, KimS.H, ChungD.R, PeckK.R, ThamlikitkulV., SoT.M, YasinR.M, HsuehP.R, CarlosC.C, HsuL.Y, BuntaranL., LalithaM.K, SongJ.H, and KoK.S.. 2013. Spread of carbapenem-resistant Acinetobacter baumannii global clone 2 in Asia and AbaR-type resistance Islands. Antimicrob. Agents Chemother. 57:5239–5246.
19.
NowakJ., ZanderE., StefanikD., HigginsP.G, RocaI., VilaJ., McConnnellM.J, CisnerosJ.M, SeifertH., and MagicBullet Working Group WP4. 2017. High incidence of pandrug-resistant Acinetobacter baumannii isolates collected from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. J. Antimicrob. Chemother. 72:3277–3282.
20.
LeungtongkamU., ThummeepakR., WongprachanS., ThongsukP., KittiT., KetwongK., RuncharoenC., ChantratitaN., and SitthisakS.. 2018. Dissemination of blaOXA-23, blaOXA-24, blaOXA-58 and blaNDM-1 genes of Acinetobacter baumannii isolates from four tertiary hospitals in Thailand. Microb. Drug Resist. 24:55–62.
21.
Clinical and Laboratory Standards Institute. 2015. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. M100-S24. CLSI, Wayne, PA.
22.
Kalai BlaguiS., AchourW., AbbassiM.S, BejaouiM., AbdeladhimA., and Ben HassenA.. 2007. Nosocomial outbreak of OXA-18-producing Pseudomonas aeruginosa in Tunisia. Clin. Microbiol. Infect. 13:794–800.
23.
KolarM., BardonJ., ChromaM., HricovaK., StosovaT., SauerP., and KoukalovaD.. 2010. ESBL and AmpC beta-lactamase producing Enterobacteriaceae in poultry in the Czech Republic. Vet. Med. Czech. 55:119–124.
24.
LeeH. W., KohY.M, KimJ., LeeJ.C, LeeY.C, SeolS.Y, and KimJ.. 2008. Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces. Clin. Microbiol. and Infect. 14:49–54.
25.
PoirelL., Le ThomasI., NaasT., KarimA., and NordmannP.. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum beta-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622–632.
26.
PoirelL., WalshT.R, CuvillierV., and NordmannP.. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70:119–23.
27.
WoodfordN., EllingtonM.J, CoelhoJ.M, TurtonJ.F, WardM.E, BrownS., AmyesS.G, and LivermoreD.M.. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents. 27:351–353.
28.
HoutB., OumC., MenP., VannyV., SupapromC., HeangV., RachmatA., ProutyM., NewellS., HarrisonD., NoorS., GolloglyJ., ThoL., KimY.J, and FordG.. 2015. Drug resistance in bacteria isolated from patients presenting with wounds at a non-profit Surgical Center in Phnom Penh, Cambodia from 2011-2013. Trop. Dis. Travel Med. Vaccines. 1:1–11.
29.
RuizM., MartiS., Fernandez-CuencaF., PascualA., and VilaJ.. 2007. Prevalence of IS(Aba1) in epidemiologically unrelated Acinetobacter baumannii clinical isolates. FEMS Microbiol. Lett. 274:63–66.
30.
BlackwellG.A., HoltK.E, BentleyS.D, HsuL.Y, and HallR.M. 2017. Variants of AbGRI3 carrying the arm A gene in extensively antibiotic-resistantAcinetobacter baumannii from Singapore. J. Antimicrob. Chemother. 72:1031–1039.
31.
LiuL., CuiY., ZhengB., JiangS., YuW., ShenP., JiJ., LiL., QinN., and XiaoY.. 2016. Analysis of tigecycline resistance development in clinical Acinetobacter baumannii isolates through a combined genomic and transcriptomic approach. Sci. Rep. 31:1–12.
32.
LiouM.L., SooP.C, LingS.R, KuoH.Y, TangC.Y, and ChangK.C.. 2014. The sensor kinase BfmS Mediates virulence in Acinetobacter baumannii. J. Microbiol. Immunol. Infect. 47:275–281.
33.
TayabaliA. F., NguyenK.C, ShwedP.S, CrosthwaitJ., ColemanG., and SeligyV.L.. 2012. Comparison of the virulence potential of acinetobacter strains from clinical and environmental sources. PLoS One, 7:1–11.
34.
BartualS.G., SeifertH., HipplerC., LuzonM.A, WisplinghoffH., and Rodríguez-ValeraF.. 2005. Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii. J. Clin. Microbiol. 43:4382–4390.
35.
MatsuiM., SuzukiS., SuzukiM., ArakawaY., and ShibayamaK.. 2013. Rapid discrimination of Acinetobacter baumannii international clone II lineage by pyrosequencing SNP analyses of blaOXA-51-like genes. J. Microbiol. Methods. 94:121–124.
36.
JoshiN.A., and FassJ.N.. 2011. Sickle: A sliding-window, adaptive, quality-based trimming tool for FastQ files (Version 1.33) [Software] Available at https://github.com/najoshi/sickle.
37.
BankevichA., NurkS., AntipovD., GurevichA.A, DvorkinM., KulikovA.S, LesinV.M, NikolenkoS.I, PhamS., PrjibelskiA.D, PyshkinA.V, SirotkinA.V, VyahhiN., TeslerG., AlekseyevM.A, and PevznerP.A.. 2012. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19:455–477.
38.
AzizR.K., BartelsD., BestA.A, DeJonghM., DiszT., EdwardsR.A, FormsmaK., GerdesS., GlassE.M, KubalM., MeyerF., OlsenG.J, OlsonR., OstermanA.L, OverbeekR.A, McNeilL.K, PaarmannD., PaczianT., ParrelloB., PuschG.D, ReichC., StevensR., VassievaO., VonsteinV., WilkeA., and ZagnitkoO.. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics. 9:75.
39.
LarsenM.V., CosentinoS., RasmussenS., FriisC., HasmanH., MarvigR.L, JelsbakL., Sicheritz-PonténT., UsseryD.W, AarestrupF.M, and LundO.. 2012. Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 50:1355–1361.
40.
ZankariE., HasmanH., CosentinoS., VestergaardM., RasmussenS., LundO., AarestrupF.M, and LarsenM.V.. 2012. Identification of acquired antimicrobial resistance genes. J. Antimicrob. Chemother. 67:2640–2644.
41.
LeanS.S., and YeoC.C.. 2017. Small, enigmatic plasmids of the nosocomial pathogen, Acinetobacter baumannii: good, bad, who knows? Front. Microbiol. 8:1547.
42.
KaasR.S., LeekitcharoenphonP., AarestrupF.M, and LundO.. 2014. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS One. 9:e104984.
43.
DahdouhE., Gómez-GilR., PachoS., MingoranceJ., DaoudZ., and SuárezM.. 2017. Clonality, virulence determinants, and profiles of resistance of clinical Acinetobacter baumannii isolates obtained from a Spanish hospital. PLoS One. 12:1–18.
44.
FarshadzadehZ., HashemiF.B, RahimiS., PourakbariB., EsmaeiliD., HaghighiM.A, MajidpourA., ShojaaS., RahmaniiM., GharesiS., AziemzadehM., and BahadorA.. 2015. Wide distribution of carbapenem resistant Acinetobacter baumannii in burns patients in Iran. Front. Microbiol. 6:1–10.
45.
HsuL.Y., ApisarnthanarakA., KhanE., SuwantaratN., GhafurA., and TambyahP.A.. 2017. Carbapenem-resistant Acinetobacter baumannii and Enterobacteriaceae in South and Southeast Asia. Clin. Microbiol. Rev. 30:1–22.
46.
KhorsiK., MessaiY., HamidiM., AmmariH., and BakourR.. 2015. High prevalence of multidrug-resistance in Acinetobacter baumannii and dissemination of carbapenemase-encoding genes blaOXA-23-like, blaOXA-24-like and blaNDM-1 in Algiers hospitals. Asian. Pac. J. Trop. Med. 8:438–446.
47.
KohT.H., SngL.H, WangG.C, HsuL.Y, and ZhaoY.. 2007. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J. Antimicrob. Chemother. 59:627–632.
48.
LeeH.Y., ChangR.C, SuL.H, LiuS.Y, WuS.R, ChuangC.H, ChenC.L, and ChiuC.H.. 2012. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan. Int J. Antimicrob. Agents. 40:163–167.
49.
LiY.J., PanC.Z, FangC.Q, ZhaoZ.X, ChenH.L, GuoP.H, and ZhaoZ.W.. 2017. Pneumonia caused by extensive drug-resistant Acinetobacter baumannii among hospitalized patients: genetic relationships, risk factors and mortality. BMC Infect. Dis. 17:1–10.
50.
WangX., QiaoF., YuR., GaoY., and ZongZ.. 2013. Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study. BMC Microbiol. 13:1–8.
51.
LeungtongkamU., ThummeepakR., TasanapakK., and SitthisakS.. 2018. Acquisition and transfer of antibiotic resistance genes in association with conjugative plasmid or class 1 integrons of Acinetobacter baumannii. PLoS One. 13:e0208468.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
